- Zacks
Inari's (NARI) Expanding Product Portfolio Offsets Competition
Inari's (NARI) VTE products are driving its top line on the back of robust adoption. The company is expanding in additional indications to fuel growth and fight competition.
- Zacks
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
- Zacks
Three Reasons to Retain BD (BDX) Stock in Your Portfolio Now
BD's (BDX) robust product portfolio raises optimism about the stock.
